Jazz Pharmaceuticals plc — Director's Dealing 2015

Feb 12, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2015-02-10

Reporting Person: Tobias Jeffrey K (EVP, R&D & CMO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-02-10	Ordinary Shares	M	5000.0	$46.83	Acquired	40063	Direct
2015-02-10	Ordinary Shares	S	3000.0	$166.482	Disposed	37063	Direct
2015-02-10	Ordinary Shares	S	2000.0	$167.3361	Disposed	35063	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-02-10	Non-Qualified Stock Option (right to buy)	$46.83	M	5000.0	Disposed	2022-08-08	Ordinary Shares (5000)	Direct

Footnotes

F1: Includes 123 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 28, 2014.

F2: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.03 to $166.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.01 to $167.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F5: As of the date of this report, the remaining ordinary shares subject to this option are vested with respect to 2,682 shares and will vest with respect to 12,805 shares in equal monthly installments from March 9, 2015 to December 9, 2015 and with respect to 9,532 shares in equal monthly installments from January 9, 2016 to August 9, 2016.